Mason Street Advisors LLC purchased a new position in shares of Vitamin Shoppe Inc. (NYSE:VSI) during the second quarter, Holdings Channel reports. The fund purchased 4,744 shares of the company’s stock, valued at approximately $145,000.
A number of other large investors also recently made changes to their positions in VSI. Acrospire Investment Management LLC bought a new stake in shares of Vitamin Shoppe during the second quarter worth $135,000. BlackRock Inc. boosted its stake in shares of Vitamin Shoppe by 241.2% in the second quarter. BlackRock Inc. now owns 6,541 shares of the company’s stock worth $200,000 after buying an additional 4,624 shares during the period. Daiwa Securities Group Inc. boosted its stake in shares of Vitamin Shoppe by 932.1% in the second quarter. Daiwa Securities Group Inc. now owns 7,400 shares of the company’s stock worth $226,000 after buying an additional 6,683 shares during the period. Martingale Asset Management L P bought a new stake in shares of Vitamin Shoppe during the second quarter worth $242,000. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Vitamin Shoppe by 95.2% in the second quarter. BNP Paribas Arbitrage SA now owns 8,461 shares of the company’s stock worth $259,000 after buying an additional 4,126 shares during the period.
Vitamin Shoppe Inc. (NYSE:VSI) opened at 27.47 on Friday. Vitamin Shoppe Inc. has a 12 month low of $26.02 and a 12 month high of $34.41. The firm’s 50-day moving average is $27.16 and its 200 day moving average is $28.94. The firm has a market capitalization of $647.85 million, a price-to-earnings ratio of 16.09 and a beta of 0.55.
Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings data on Wednesday, August 3rd. The company reported $0.55 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.59 by $0.04. The company had revenue of $332.70 million for the quarter, compared to analyst estimates of $331.58 million. Vitamin Shoppe had a return on equity of 11.53% and a net margin of 3.56%. Vitamin Shoppe’s revenue was up 3.2% on a year-over-year basis. During the same period in the prior year, the business earned $0.57 earnings per share. Equities analysts predict that Vitamin Shoppe Inc. will post $2.18 earnings per share for the current year.
A number of brokerages recently weighed in on VSI. Jefferies Group reissued a “hold” rating and issued a $28.00 price target on shares of Vitamin Shoppe in a research report on Monday, September 26th. Wedbush reissued an “outperform” rating and issued a $39.00 price target on shares of Vitamin Shoppe in a research report on Wednesday, August 3rd. Zacks Investment Research raised shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a research report on Thursday, October 6th. Finally, Barclays PLC began coverage on shares of Vitamin Shoppe in a report on Thursday, September 22nd. They issued an “equal weight” rating and a $29.00 target price for the company. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and one has given a buy rating to the company. The company has an average rating of “Hold” and an average price target of $32.27.
About Vitamin Shoppe
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.
Want to see what other hedge funds are holding VSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Vitamin Shoppe Inc. (NYSE:VSI).
Receive News & Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related companies with MarketBeat.com's FREE daily email newsletter.